AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

SitaOD Met 50/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview SitaOD Met 50/1000 Tablet

Diabetica Duo 50/1000 tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabetica Duo 50/1000 may be used independently or in conjunction with other antidiabetic therapies. Optimal efficacy is achieved with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glucose levels, and other medications. Ingesting the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial for effective diabetes control, as lifestyle significantly impacts management. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; appropriate recognition and management strategies are essential. This medication is not universally suitable. Prior to commencing treatment, disclose any history of hepatic, renal, or cardiac disease, pancreatic disorders, or significant alcohol consumption to your physician. Pregnant or lactating women require medical consultation before initiating therapy. Potential drug interactions necessitate informing your doctor of all concurrent medications to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your physician will monitor kidney function and blood glucose levels throughout the treatment course.

Primary Ingredients of SitaOD Met 50/1000 Tablet

There is no text provided to rephrase.

Uses of SitaOD Met 50/1000 Tablet

Managing Type 2 Diabetes

Major Benefits of SitaOD Met 50/1000 Tablet:

Consume this medication according to your physician's prescribed dosage and regimen. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. SitaOD Met 50/1000 Tablets should be administered with a meal.

Common Side effects of SitaOD Met 50/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use SitaOD Met 50/1000 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the SitaOD Met 50/1000 Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How SitaOD Met 50/1000 Tablet works:

SitaOD Met 50/1000 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and augments insulin sensitivity. This combined action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining SitaOD Met 50/1000 tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using SitaOD Met 50/1000 Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Consult your doctor for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of SitaOD Met 50/1000 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Individuals with kidney impairment should exercise caution when using SitaOD Met 50/1000 tablets, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated for patients experiencing severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

The use of SitaOD Met 50/1000 Tablets is contraindicated in individuals with hepatic impairment; avoid use and seek medical advice.

What if you forget to take SitaOD Met 50/1000 Tablet :

Should you forget to take a SitaOD Met 50/1000 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About SitaOD Met 50/1000 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on SitaOD Met 50/1000 Tablet

SitaOD Met 50/1000 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of SitaOD Met 50/1000 Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues (including tingling, numbness in extremities, weakness, and ataxia), urinary problems, and cognitive changes. To mitigate this risk, annual supplementation with vitamin B12 is recommended by some researchers.
SitaOD Met 50/1000 Tablet may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
SitaOD Met 50/1000 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining SitaOD Met 50/1000 Tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin tablets can, rarely, cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA). This risk is heightened in patients with kidney disease, the elderly, and heavy alcohol users, so it's avoided in these groups. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, stop taking the medication and seek immediate medical attention.
SitaOD Met 50/1000 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
SitaOD Met 50/1000 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
SitaOD Met 50/1000 Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also be avoided by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining SitaOD Met 50/1000 tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Sitagliptin + Metformin (SitaOD Met 50/1000 Tablet) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged SitaOD Met 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues (including tingling, numbness in extremities, weakness, and ataxia), urinary problems, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
SitaOD Met 50/1000 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
SitaOD Met 50/1000 Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
SitaOD Met 50/1000 Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining SitaOD Met 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (like SitaOD Met 50/1000) can rarely cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also called MALA – Metformin-associated lactic acidosis). This risk is higher in patients with kidney disease, older adults, and heavy alcohol users, hence it's avoided in these groups. Symptoms include muscle aches/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged SitaOD Met 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues (including tingling, numbness in extremities, weakness, and balance problems), and urinary difficulties, potentially impacting mental function. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
SitaOD Met 50/1000 Tablet
99
MRP 115
13% off